Naltrexone News and Research

RSS
New study finds opioid dependence affects perception of cute images of babies

New study finds opioid dependence affects perception of cute images of babies

First buprenorphine implant for opioid dependence treatment gets FDA approval

First buprenorphine implant for opioid dependence treatment gets FDA approval

Naltrexone injections could reduce risk of relapse among opioid dependent individuals

Naltrexone injections could reduce risk of relapse among opioid dependent individuals

Opioids could be dangerous, deadly at high doses

Opioids could be dangerous, deadly at high doses

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

First patient enrolled in Phase 3 efficacy trial of CAM2038 for opioid dependence

First patient enrolled in Phase 3 efficacy trial of CAM2038 for opioid dependence

Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

Drug that relieves opioid-induced constipation may help some cancer patients live longer

Drug that relieves opioid-induced constipation may help some cancer patients live longer

FDA awards research grants to boost product development for patients with rare diseases

FDA awards research grants to boost product development for patients with rare diseases

New guideline on the use of prescription medications for treatment of opioid addiction

New guideline on the use of prescription medications for treatment of opioid addiction

Drug addiction expert uncovers molecular mechanisms that contribute to addiction resistance

Drug addiction expert uncovers molecular mechanisms that contribute to addiction resistance

Egalet announces top-line results from Egalet-002 study in moderate drinkers

Egalet announces top-line results from Egalet-002 study in moderate drinkers

New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Study could lead to potential drug treatment for fighting addiction

Study could lead to potential drug treatment for fighting addiction

Endocrine Society issues guideline on prescribing drugs to manage obesity, promote weight loss

Endocrine Society issues guideline on prescribing drugs to manage obesity, promote weight loss

Added benefit of nalmefene not proven for alcohol dependence

Added benefit of nalmefene not proven for alcohol dependence

Findings show that blockade of OGF-OGFr interfacing influences diabetic wound healing

Findings show that blockade of OGF-OGFr interfacing influences diabetic wound healing

FDA approves Contrave extended-release tablets for chronic weight management

FDA approves Contrave extended-release tablets for chronic weight management

Naltrexone may be effective in diminishing ICD symptoms in PD patients, study finds

Naltrexone may be effective in diminishing ICD symptoms in PD patients, study finds